APA (7th ed.) Citation

Bratcher, A., Jones, J. M., Meyer III, W. A., Waheed, R., Yazgi, H., Harris, A., . . . Clarke, K. E. N. (2025). Anti-nucleocapsid SARS-CoV-2 antibody seroprevalence in previously infected persons with immunocompromising conditions—United States, 2020–2022. PLoS ONE, 20(1), 1. https://doi.org/10.1371/journal.pone.0313620

Chicago Style (17th ed.) Citation

Bratcher, Anna, Jefferson M. Jones, William A. Meyer III, Rehan Waheed, Huda Yazgi, Aaron Harris, Adi V. Gundlapalli, and Kristie E. N. Clarke. "Anti-nucleocapsid SARS-CoV-2 Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions—United States, 2020–2022." PLoS ONE 20, no. 1 (2025): 1. https://doi.org/10.1371/journal.pone.0313620.

MLA (9th ed.) Citation

Bratcher, Anna, et al. "Anti-nucleocapsid SARS-CoV-2 Antibody Seroprevalence in Previously Infected Persons with Immunocompromising Conditions—United States, 2020–2022." PLoS ONE, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1371/journal.pone.0313620.